Discgenics, Inc.
About
Overview
We are a biotechnology company developing advanced spinal stem cell therapeutics to treat patients with diseases of the intervertebral disc.
Our Impact
With back pain being such a significant problem globally and a burden on the healthcare system, our technology has the potential to increase quality of life for patients and to reduce costs to the healthcare system.
A Unique Tool to Battle Back Pain
DiscGenics is the only company to utilize allogeneic therapeutic progenitor cells derived from intervertebral disc within the spine to treat the disc.
A progenitor cell is a partially differentiated adult stem cell.
We have a patented technology for isolating cells directly from adult human disc tissue and expanding these cells into our proprietary Discogenic Cells.
Contact
675 Arapeen Drive, Suite 106
Salt Lake City, Utah
84108
United States